Carl Ola Landgren
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
July, 2024
July 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jun
Carl Ola Landgren
Jun 13, 2024, 05:46 |
Societies
Carl Ola Landgren: Getting ready with Mohamad Mohty for tomorrow’s opening session at EHA2024
Carl Ola Landgren shared on X: "Getting ready together with Mohamad Mohty for tomorrow’s opening…
Apr 26, 2024, 14:15 |
Drugs
Carl Ola Landgren: With Minimal Residual Disease (MRD) as an early endpoint for accelerated approval of new multiple myeloma drugs, patients access to new therapies will be much quicker
Apr 14, 2024, 12:56 |
Insight
Carl Ola Landgren: Can MRD serve as early endpoint for accelerated approval in myeloma, to facilitate patient’s access to new drugs
Carl Ola Landgren, Professor of Medicine, Chief of Myeloma Division at University of Miami, shared…
Apr 13, 2024, 03:43 |
Blog
FDA ODAC voted 12-0. Historic victory in multiple myeloma
On April 12, 2024, FDA ODAC voted 12-0 in favor of using minimal residual disease…
Mar 19, 2024, 21:14 |
Blog
Carl Ola Landgren: We had full program in Coral Gables for Multiple Myeloma Awarness Month
Carl Ola Landgren, Chief of Myeloma Division and Translational Clinical Oncology Program at Sylvester Comprehensive…
All:
5
Posts:
1 - 100
OncoDaily at ASCO 2024: OncoDaily Party, Yvonne Award and much more
Tedros Adhanom Ghebreyesus received University of Nicosia’s Honorary Doctorate
Lisa A. Lacasse: A major milestone towards Congress passing the bipartisan MCED Act
July is Sarcoma Awareness Month
25 Posts You Should Not Miss From ESMOGI24!
Facebook
RSS Feed
Twitter
Linkedin
Youtube